Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sharp Laboratories of America (SLA) is the U.S.-based research and development subsidiary of Sharp Corporation, specializing in the creation of next-generation technologies for healthcare and consumer electronics. Based in Camas, Washington, SLA focuses on high-impact areas such as medical devices, lab-on-a-chip diagnostics, and digital health platforms. The laboratory leverages Sharp's expertise in microelectronics and display technology to develop advanced biosensors and microfluidic systems for point-of-care testing. Their healthcare initiatives often involve the integration of artificial intelligence and computer vision to improve clinical outcomes and patient monitoring. As a key innovation hub, SLA collaborates with academic institutions and industry partners to transition emerging technologies from the lab to the global market. The company plays a critical role in Sharp's strategic shift toward the health and wellness sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sharp Laboratories of America.